Shilpa Medicare Ltd

Shilpa Medicare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 May 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 23 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Shilpa Medicare Ltd has witnessed a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. This change reflects evolving market perceptions amid strong stock returns and a competitive pharmaceutical sector landscape. A detailed analysis of its price-to-earnings (P/E), price-to-book value (P/BV), and other key metrics against historical and peer averages reveals the nuances behind this valuation adjustment and what it means for investors.

Surging to a new 52-week high of Rs 638.35 on 14 Jul 2026, Shilpa Medicare Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market despite a subdued Sensex. The stock’s four-day consecutive gain, delivering a 7.33% return in this period, underscores a strong technical alignment that has propelled it well above its 52-week low of Rs 260.

Shilpa Medicare Ltd has seen a marked shift in its valuation parameters, moving from an expensive to a very expensive rating, driven by a surge in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios. Despite this, the small-cap pharmaceutical company has delivered exceptional returns over recent periods, outperforming the Sensex by a wide margin, prompting a reassessment of its investment appeal.

Shilpa Medicare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 12 July 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance.

With a decisive break above Rs 633.6 on 10 Jul 2026, Shilpa Medicare Ltd has reached a new 52-week high, extending its impressive 43.6% rally over the past year. This milestone comes amid a backdrop of strong technical momentum and a market environment where the Sensex is also trading positively, underscoring the stock's robust price action.

With a decisive surge to Rs 628.85 on 09 Jul 2026, Shilpa Medicare Ltd has reached a new 52-week high, marking a remarkable 141% rally from its low of Rs 260 over the past year. This milestone reflects a strong confluence of technical momentum indicators and sustained price strength that has outpaced the broader market.

Shilpa Medicare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 01 July 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Surging past its previous peaks, Shilpa Medicare Ltd touched a fresh 52-week high of Rs 603.05 on 30 Jun 2026, marking a significant milestone in its price journey. This advance comes amid a backdrop of strong technical momentum, with the stock outperforming its sector and maintaining gains over consecutive sessions.

With a decisive surge to Rs 597.4 on 23 Jun 2026, Shilpa Medicare Ltd has reached a fresh 52-week high, marking a 33.42% gain over the past year and significantly outperforming the Sensex, which declined 6.92% in the same period. This milestone comes amid a complex market backdrop where the broader indices have faltered, underscoring the stock’s strong price momentum and technical alignment.

The Sensex declined 0.74% on 23 Jun 2026 while Shilpa Medicare Ltd surged 7.03%, touching an intraday high of Rs 588.4. This 6.26-percentage-point outperformance over the Pharmaceuticals & Biotechnology sector highlights a distinctly stock-specific rally rather than a market-wide lift.

Shilpa Medicare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 May 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the company’s current position as of 20 June 2026, providing investors with the most up-to-date view of the stock’s fundamentals, returns, and technical outlook.

With a decisive break above Rs 588.65 on 18 Jun 2026, Shilpa Medicare Ltd has reached a fresh 52-week high, extending its impressive 25.81% gain over the past year against the Sensex’s decline of 5.21%. This milestone reflects a sustained momentum driven by a confluence of bullish technical indicators and steady price appreciation.

With a decisive break above Rs 578 on 10 Jun 2026, Shilpa Medicare Ltd has reached a fresh 52-week high, extending its impressive 21.62% gain over the past year against the Sensex’s decline of 9.63%. This milestone reflects a strong technical momentum that has been building steadily over recent sessions.

Surging past its previous peaks, Shilpa Medicare Ltd touched a fresh 52-week high of Rs 578 on 09 Jun 2026, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical signals and sustained outperformance relative to its sector and the broader market.

The Sensex edged up 0.55% on 09 Jun 2026, but Shilpa Medicare Ltd outpaced the broader market with a 7.23% gain, reaching an intraday high of Rs 557.2. This 3.76-percentage-point outperformance over the Pharmaceuticals & Biotechnology sector signals a distinctly stock-specific rally rather than a market-wide lift.